Sign Up to like & get
recommendations!
2
Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.130
Abstract: This report identifies if the adoption of the Methotrexate Intolerance Severity Score improves the documentation and objective evaluation of the experiences of patients with Juvenile Idiopathic Arthritis, currently treated with methotrexate within in a local…
read more here.
Keywords:
rheumatology;
intolerance;
paediatric rheumatology;
intolerance severity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.6077
Abstract: Background Methotrexate (MTX) is the first-choice disease-modifying anti-rheumatic drug (DMARD) for the treatment of juvenile idiopathic arthritis (JIA). During therapy, there are frequent reports of discontinuation of MTX, either by physicians or patient’s own conduct.…
read more here.
Keywords:
mtx intolerance;
mtx;
intolerance severity;
severity score ... See more keywords